North Carolina drops coverage for Wegovy and Ozempic, with implications for anti-obesity drug market projected to hit $100B by 2030

Other states and insurers are also facing rising costs and pressure from drugmakers to cover the medications.

Posted from: this blog via Microsoft Power Automate.